Dividend Update: January 2023

  General Overview

New year, new chances? That's certainly the way it seemed as the market - with no real impetus behind it (apart from the slightly falling, but still very high inflation) - climbed. My portfolio was no exception as it went up a very flattering 3,1%. 

I also, by the skin of my teeth, managed to (just barely) cross the 300€ dividend treshhold I'm hoping to consistently be above this year. In total, I received 302,71€ in dividends. On the one hand, it's gratifying; on the other hand, I know that at the beginning of the year I'm still benefiting from the tax-free gains which I will have eaten up probably around March or April.

1. Total Energies: 7,76
   
2. Iron Mountain: 7,88
   
3. PepsiCo: 9,23 
4. AGNC: 5,05
   
5. Vici Properties: 1,28
   
6. Altria: 15,17
   
7. iShares STOXX Global Select Dividend 100: 42,73
   
8. Realty Income: 27,29
9. Spirit Realty Capital: 0,82
   
10. WP Carey: 40,39
11. EPR Properties: 3,02
    
12. Main Street Capital: 17,32
13. Orion Office: 0,47
    
14. Philip Morris: 24,54
    
15. Innovative Industrial Properties: 5,19
    
16. Starwood Property Trust: 2,89
    
17. Stag Industrial: 0,48
    
18. SL Green Realty: 2,34
    
19. Goldman Sachs BDC: 27,31
20. Bank of Nova Scotia: 6,37
21. JPMorgan Chase: 3,12
    
22. LTC Properties: 2,53
    
23. Calamos Strategic Total Return Fund: 3,37
24. Blackrock Utilities, Infrastructure & Power Opportunities Trust: 3,27
    
25. Cohen&Steers Quality Realty Income Fund: 9,17
26. Blackrock Enhanced Capital Income Fund: 3,84
    
27. Blackrock Science and Technology Trust II:  4,73
    
28. Cohen & Steers REIT & Preferred Income Fund: 2,22
    

In total, I received dividends from 28 stocks / funds with the biggest sums coming from the iShares STOXX Global Select Dividend 100 ETF and from WP Carey. On average, I received a daily dividend of 9.76 and 10.81 from ever stock or fund. 

Winners & Losers

The biggest climbers this month were the ever-falling Vonovia (25% into which I had been averaging down to) and ASML (25% on very good earnings). The biggest losers were Pfizer (-16%) after very good earnings, but doubt that the profits will fall away with the "end of the pandemic" and NextEraEnergy (-14%) after subpar earnings.